Myelofibrosis in a patient with pachydermoperiostosis

C Bachmeyer; L Blum; J-F Cadranel; J-F Delfraissy

doi:10.1111/j.1365-2230.2005.01891.x

Myelofibrosis in a patient with pachydermoperiostosis

Clin Exp Dermatol. 2005 Nov;30(6):646-8. doi: 10.1111/j.1365-2230.2005.01891.x.

Authors

C Bachmeyer¹, L Blum, J-F Cadranel, J-F Delfraissy

Affiliation

¹ Service de Médecine Interne, Hôpital Tenon, Paris, France. claude.bachmeyer@tnn.ap-hop-paris.fr

PMID: 16197378
DOI: 10.1111/j.1365-2230.2005.01891.x

Abstract

Pachydermoperiostosis (idiopathic or primary hypertrophic osteoarthropathy) is a rare condition of unknown origin involving the skin and the skeleton, with an autosomal dominant transmission. We report a case of anaemia in a patient with pachydermoperiostosis indicating myelofibrosis, and review the literature and the pathogenetic mechanisms.

Publication types

Case Reports
Review

MeSH terms

Acitretin / therapeutic use
Adult
Anemia / drug therapy
Anemia / etiology*
Fibula / diagnostic imaging
Humans
Keratolytic Agents / therapeutic use
Male
Osteoarthropathy, Secondary Hypertrophic / complications*
Osteoarthropathy, Secondary Hypertrophic / diagnosis
Primary Myelofibrosis / complications*
Primary Myelofibrosis / diagnosis
Radiography
Tibia / diagnostic imaging

Substances

Keratolytic Agents
Acitretin